Christine Peterson writes, lectures, and briefs the media on coming powerful technologies, especially nanotechnology and life extension. She is Co-Founder and Past President of Foresight Institute, the leading nanotech public interest group. Foresight educates the public, technical community, and policymakers on nanotechnology and its long-term effects.
She serves on the Advisory Board of the Machine Intelligence Research Institute, and has served on California’s Blue Ribbon Task Force on Nanotechnology and the Editorial Advisory Board of NASA’s Nanotech Briefs.
She has often directed Foresight Conferences on Molecular Nanotechnology, organized Foresight Institute Feynman Prizes, and chaired Foresight Vision Weekends.
She lectures on nanotechnology to a wide variety of audiences, focusing on making this complex field understandable, and on clarifying the difference between near-term commercial advances and the “Next Industrial Revolution” arriving in the next few decades.
Her work is motivated by a desire to help Earth’s environment and traditional human communities avoid harm and instead benefit from expected dramatic advances in technology. This goal of spreading benefits led to an interest in new varieties of intellectual property including open source software, a term she is credited with originating.
Wearing her for-profit hat, she chairs the Personalized Life Extension Conference series. In 1991 she coauthored Unbounding the Future: the Nanotechnology Revolution (Morrow, full text online), which sketches nanotechnology’s potential environmental and medical benefits as well as possible abuses. An interest in group process led to coauthoring Leaping the Abyss: Putting Group Genius to Work (knOwhere Press, 1997, full text online) with Gayle Pergamit.
Peterson holds a bachelor’s degree in chemistry from MIT.
Past lectures: Recent or Earlier
Video of keynote at O’Reilly Open Source Convention
Video of Chairman’s Intro from Personalized Life Extension Conference (22 min)
PO Box 61058
Palo Alto, CA 94306 USA
tel +1 (650) 289 0860
fax +1 (650) 289 0863